Scinovex
review Open AccessTop 1% cited

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

CA A Cancer Journal for Clinicians · 2017 · Vol. 67(5) · pp. 378–397
Manuel Picon‐RuizCynthia Morata‐TarifaJaneiro J. Valle‐GoffinEitan FriedmanJoyce M. Slingerland

Abstract

Answer questions and earn CME/CNE Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m<sup>2</sup> ), and of these, over 600 million were obese (BMI ≥30 kg/m<sup>2</sup> ). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378-397. © 2017 American Cancer Society.

Cancer Risks and FactorsMetabolism, Diabetes, and CancerCancer, Lipids, and MetabolismMedicineBreast cancerOverweightObesityCancerInternal medicineBody mass indexPopulationOncologyDisease

MeSH terms

Adipose TissueBreast NeoplasmsFemaleHumansLife StyleObesityRisk FactorsWeight GainWeight LossExerciseComorbidityPremenopausePostmenopause

Funding

  • Breast Cancer Research Foundation
  • Susan G. Komen
  • National Institutes of Health
Citations
942
FWCI
26.49
field-weighted impact
References
212
Percentile
100%
vs. same field & year
Citations per year
References
Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women
JNCI Journal of the National Cancer Institute · 2003 · 1,084 citations
Overweight as an avoidable cause of cancer in Europe
International Journal of Cancer · 2001 · 750 citations
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Cancer Letters · 2008 · 591 citations
The role of intratumoral and systemic IL-6 in breast cancer
Breast Cancer Research and Treatment · 2013 · 369 citations
Coordinated regulation of myeloid cells by tumours
Nature reviews. Immunology · 2012 · 3,481 citations
Cancer Stem Cells: Current Status and Evolving Complexities
Cell stem cell · 2012 · 1,294 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.